Waystar to Acquire Iodine Software for $1.25 Billion
Waystar has announced a definitive agreement to acquire Iodine Software for $1.25 billion, aiming to enhance its AI capabilities in healthcare payments.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Waystar has announced a definitive agreement to acquire Iodine Software for $1.25 billion, aiming to enhance its AI capabilities in healthcare payments.
Aidoc has announced a $150 million funding round to accelerate the development of its clinical AI model, CARE, aimed at enhancing clinical decision-making for 100 million patients.
LenioBio has been awarded €3.7 million from the EU4Health program to advance its ALiCE® protein expression system, aiming for cost-effective and rapid production of protein-based medicines.
AIRS Medical is expanding its AI-powered MRI solution, SwiftMR, across Latin America through strategic partnerships, with over 150 imaging centers in Brazil adopting the technology.
Dash Bio has raised $11 million in funding, led by The Aligned Fund, to advance its automated bioanalysis platform, bringing total funding to $17.5 million.
BullFrogAI has published a white paper detailing how its bfLEAP platform aims to improve drug discovery success rates by using AI to navigate complex biological data.
Linus Health will present its AI-powered digital cognitive assessment solutions at the Alzheimer's Association International Conference 2025, focusing on early detection and personalized brain health care.
BostonGene has been awarded the 2025 North American Enabling Technology Leadership Award by Frost & Sullivan for its AI-powered platform that integrates multiomics data to advance precision oncology.
Kontakt.io has extended its Staff Safe solution to cover outdoor areas in hospitals, providing comprehensive safety coverage across entire healthcare campuses.
Answer ALS has announced a new AI-driven initiative, LADDIA, in collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane University to advance ALS treatment discovery.
The AI in Ophthalmology market is projected to grow from $209.23 million in 2024 to $1.36 billion by 2030, driven by advancements in imaging technology and teleophthalmology services.
TileDB and Databricks have announced a partnership to integrate multimodal data for AI-driven healthcare advancements, as stated in a press release.
Somatus, a leader in value-based kidney and heart care, now manages over 500,000 patients across all 50 states and DC, announced in a press release.
AbsoluteCare has secured $135 million in equity financing from investors including CVS Health Ventures and Kinderhook Industries to expand its value-based healthcare services.
Remedy Logic has announced a partnership with RADIN Health to integrate AI solutions for spine MRI interpretation, enhancing radiology workflows.
Regard has introduced a new AI-powered platform that combines patient chart data with physician conversations to recommend diagnoses, as announced in a press release.
Elix has announced that its AI drug discovery platform, Elix Discovery™, has been adopted by Eisai to enhance drug discovery processes.
Philips has introduced the ECG AI Marketplace, featuring Anumana's FDA-cleared LEF algorithm, to enhance cardiac diagnostics.
RIVANNA has received FDA 510(k) clearance for its Accuro 3S ultrasound system and SpineNav-AI software, enabling their use in U.S. hospitals for enhanced needle and catheter placement.
Springbok Analytics has published a new AI-based model to predict disease progression in facioscapulohumeral muscular dystrophy (FSHD), enhancing trial design and biomarker development.